# Inuvo, Inc.: overview INUV · NYSE · CIK 829323 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/inuv.md) · [Financials](/companies/inuv/financials.md) · [Filings](/companies/inuv/filings.md) · [Insiders](/companies/inuv/insiders.md) Latest reported revenue: [$7.5m](/filings/0001654954-26-007480.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:Revenues, accession 0001654954-26-007480). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [22.4](/filings/0001654954-25-012670.md) | [26.2 d](/filings/0001654954-26-001943.md) | [26.7](/filings/0001654954-26-004909.md) | [22.7](/filings/0001654954-26-007480.md) | [22.6](/filings/0001654954-25-012670.md) | [14.3 d](/filings/0001654954-26-001943.md) | [7.9](/filings/0001654954-26-004909.md) | [7.5](/filings/0001654954-26-007480.md) | | Gross margin | % | [88.4%](/filings/0001654954-25-012670.md) | [83.1% d](/filings/0001654954-26-001943.md) | [79.0%](/filings/0001654954-26-004909.md) | [75.4%](/filings/0001654954-26-007480.md) | [73.4%](/filings/0001654954-25-012670.md) | [66.4% d](/filings/0001654954-26-001943.md) | [46.2%](/filings/0001654954-26-004909.md) | [44.2%](/filings/0001654954-26-007480.md) | | Operating margin | % | [(8.7%)](/filings/0001654954-25-012670.md) | [0.8% d](/filings/0001654954-26-001943.md) | [(6.6%)](/filings/0001654954-26-004909.md) | [(9.0%)](/filings/0001654954-26-007480.md) | [(7.4%)](/filings/0001654954-25-012670.md) | [(8.5%) d](/filings/0001654954-26-001943.md) | [(49.0%)](/filings/0001654954-26-004909.md) | [(40.4%)](/filings/0001654954-26-007480.md) | | Net margin | % | [(9.1%)](/filings/0001654954-25-012670.md) | [0.5% d](/filings/0001654954-26-001943.md) | [(4.7%)](/filings/0001654954-26-007480.md) | [(6.6%)](/filings/0001654954-26-007480.md) | [(7.7%)](/filings/0001654954-25-012670.md) | [(4.2%) d](/filings/0001654954-26-001943.md) | [23.9%](/filings/0001654954-26-007480.md) | [(53.6%)](/filings/0001654954-26-007480.md) | | Diluted EPS | $ per share | [(0.15)](/filings/0001654954-25-012670.md) | not reported | [(0.09)](/filings/0001654954-26-004909.md) | [(0.10)](/filings/0001654954-26-007480.md) | [(0.12)](/filings/0001654954-25-012670.md) | not reported | [0.13](/filings/0001654954-26-004909.md) | [(0.27)](/filings/0001654954-26-007480.md) | | Free cash flow | $m | [0.6 d](/filings/0001654954-25-012670.md) | [(0.1) d](/filings/0001654954-26-001943.md) | [(0.8)](/filings/0001654954-26-004909.md) | [(0.3) d](/filings/0001654954-26-007480.md) | [(2.0) d](/filings/0001654954-25-012670.md) | [(0.3) d](/filings/0001654954-26-001943.md) | [1.2](/filings/0001654954-26-004909.md) | [(2.5) d](/filings/0001654954-26-007480.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [59.8](/filings/0000829323-23-000010.md) | [75.6](/filings/0001654954-24-002423.md) | [73.9](/filings/0001654954-25-002032.md) | [83.8](/filings/0001654954-26-001943.md) | [86.2](/filings/0001654954-26-001943.md) | | Gross margin | % | [73.4%](/filings/0000829323-23-000010.md) | [60.0%](/filings/0001654954-24-002423.md) | [85.8%](/filings/0001654954-25-002032.md) | [85.6%](/filings/0001654954-26-001943.md) | [74.5%](/filings/0001654954-26-001943.md) | | Operating margin | % | [(13.0%)](/filings/0000829323-23-000010.md) | [(16.7%)](/filings/0001654954-24-002423.md) | [(14.1%)](/filings/0001654954-25-002032.md) | [(6.6%)](/filings/0001654954-26-001943.md) | [(7.8%)](/filings/0001654954-26-001943.md) | | Net margin | % | [(12.7%)](/filings/0000829323-23-000010.md) | [(17.3%)](/filings/0001654954-24-002423.md) | [(14.1%)](/filings/0001654954-25-002032.md) | [(6.9%)](/filings/0001654954-26-001943.md) | [(5.9%)](/filings/0001654954-26-001943.md) | | Diluted EPS | $ per share | [(0.06)](/filings/0000829323-23-000010.md) | [(0.11)](/filings/0000829323-23-000010.md) | [(0.08)](/filings/0001654954-25-002032.md) | [(0.04)](/filings/0001654954-25-002032.md) | not reported | | Free cash flow | $m | [(6.9)](/filings/0000829323-23-000010.md) | [(7.3)](/filings/0001654954-24-002423.md) | [(4.2)](/filings/0001654954-25-002032.md) | [(1.6)](/filings/0001654954-26-001943.md) | [(3.4)](/filings/0001654954-26-001943.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/inuv/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [PERKINS CAPITAL MANAGEMENT INC](/funds/884300.md) | 2026-06-30 | $6.5m | 515,011 | | Reduced −67,280 | | [ARMISTICE CAPITAL, LLC](/funds/1601086.md) | 2026-06-30 | $2.0m | 1,622,307 | | New +1,622,307 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $659.4k | 523,329 | | Added +17,451 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $169.1k | 134,188 | | Reduced −24,759 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $156.0k | 123,814 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $79.3k | 62,902 | | Unchanged | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $72.4k | 57,441 | | Reduced −31,800 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $69.1k | 54,805 | | Unchanged | | [Centiva Capital, LP](/funds/1692507.md) | 2026-06-30 | $61.1k | 48,485 | | Added +20,178 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $45.0k | 35,690 | | New +35,690 | ## Recent filings [All 1,109 filings](/companies/inuv/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-11 | 21:29 ET | [8-K](/filings/0001654954-26-007482.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-007482 | | 2026-08-11 | 21:19 ET | [10-Q](/filings/0001654954-26-007480.md) | Quarterly report, period 2026-06-30 | 0001654954-26-007480 | | 2026-07-08 | 21:28 ET | [8-K](/filings/0001654954-26-006551.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-006551 | | 2026-07-01 | 19:33 ET | [8-K](/filings/0001654954-26-006459.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-26-006459 | | 2026-06-23 | 19:19 ET | [8-K](/filings/0001654954-26-006141.md) | 5.07 Shareholder vote results | 0001654954-26-006141 | | 2026-05-14 | 20:58 ET | [10-Q](/filings/0001654954-26-004909.md) | Quarterly report, period 2026-03-31 | 0001654954-26-004909 | | 2026-05-14 | 20:32 ET | [8-K](/filings/0001654954-26-004902.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-004902 | | 2026-04-30 | 20:01 ET | [DEF 14A](/filings/0001654954-26-004157.md) | Proxy statement, period 2026-04-30 | 0001654954-26-004157 | | 2026-04-03 | 12:58 ET | [8-K](/filings/0001654954-26-003232.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-26-003232 | | 2026-03-05 | 22:19 ET | [10-K](/filings/0001654954-26-001943.md) | Annual report, period 2025-12-31 | 0001654954-26-001943 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001654954-26-001943.md), filed Mar 5, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/29e2abf3-b6cc-4f55-9d0a-9e98ef816ed3) ## About the filer - CIK: 829323 - Tickers: INUV - Exchange: NYSE - SIC code: 7310 Services-Advertising - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.